Hepatitis C Virus Infection Terminated Phase 3 Trials for Ledipasvir (DB09027)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0033268 (Hepatitis C Virus Infection) | Terminated | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02600351 | Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies | Treatment |